Skip to main content

Want a detailed portfolio tracker?

Immunovant (IMVT) P/E (2019 - 2026)

Immunovant (IMVT) P/E from Dec 31, 2019 to Jul 21, 2026. The TTM Immunovant (IMVT) P/E is -14.65. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Immunovant (IMVT)

YearP/EChange
2026-14.65+49.79%
2025-9.78+3.14%
2024-9.48-55.95%
2023-21.52+84.51%
2022-11.66+76.00%
2021-6.63-84.60%
2020-43.02-43.95%
2019-76.76N/A

Comparison Immunovant (IMVT) P/E with competitors

Immunovant (IMVT) P/E is -14.65.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.51%
FGENFibroGen Inc0.24-101.64%
CHRSCoherus Biosciences Inc0.85-105.79%
FBIOFortress Biotech Inc0.95-106.48%
ORMPOramed Pharmaceuticals Inc1.50-110.26%
AGENAgenus Inc3.01-120.55%
INVAInnoviva Inc3.15-121.53%
VXRTVaxart Inc3.55-124.24%
CRMDCorMedix Inc3.63-124.77%
CVACCureVac N.V.4.45-130.35%
GLPGGalapagos NV4.86-133.17%
SRPTSarepta Therapeutics Inc4.88-133.33%
ABEOAbeona Therapeutics Inc5.39-136.78%
ABUSArbutus Biopharma Corp5.60-138.20%
ZVRAZevra Therapeutics Inc5.89-140.19%
SPROSpero Therapeutics Inc6.23-142.52%
CGENCompugen Ltd6.31-143.11%
RIGLRigel Pharmaceuticals6.87-146.92%
SLXNSilexion Therapeutics Corp7.30-149.81%
OMEROmeros Corporation9.26-163.21%
AUPHAurinia Pharmaceuticals Inc9.58-165.44%
PLXProtalix BioTherapeutics Inc10.89-174.36%
ACADAcadia Pharmaceuticals Inc11.73-180.08%
TBPHTheravance Biopharma Inc12.26-183.72%
ADMAAdma Biologics Inc12.42-184.78%
HRMYHarmony Biosciences Holdings Inc13.82-194.36%
SABSSAB Biotherapeutics Inc14.14-196.51%
NAGENiagen Bioscience Inc14.82-201.17%
INCYIncyte Corp15.82-208.03%
REGNRegeneron Pharmaceuticals Inc15.86-208.26%
PBYIPuma Biotechnology Inc17.32-218.22%
CPRXCatalyst Pharmaceuticals Inc17.44-219.07%
EXELExelixis Inc17.54-219.74%
TGTXTG Therapeutics Inc18.97-229.49%
MDXGMimedx Group Inc20.55-240.32%
XOMAXOMA Royalty Corp22.87-256.18%
ARGXArgen X SE24.30-265.90%
CTMXCytomX Therapeutics Inc24.82-269.47%
XOMAOXOMA Royalty Corp25.34-273.04%
HALOHalozyme Therapeutics Inc25.62-274.95%
XOMAPXOMA Royalty Corp25.67-275.27%
VRTXVertex Pharmaceuticals Inc27.99-291.14%
RPRXRoyalty Pharma plc - Class A28.69-295.87%
SLNOSoleno Therapeutics Inc29.02-298.11%
ASNDAscendis Pharma A/S30.09-305.41%
LGNDLigand Pharmaceuticals Inc - Class B37.91-358.85%
APLSApellis Pharmaceuticals Inc39.02-366.42%
BMRNBiomarin Pharmaceutical Inc42.21-388.21%
KRYSKrystal Biotech Inc45.34-409.59%
ONCBeiGene Ltd69.54-574.79%
PHARPharming Group N.V.75.03-612.24%
TECHBio-Techne Corp101.96-796.13%
VCELVericel Corp109.92-850.50%
ALNYAlnylam Pharmaceuticals Inc117.96-905.42%
GMABGenmab140.29-1057.85%
TLXTelix Pharmaceuticals Ltd162.15-1207.11%
CORTCorcept Therapeutics Inc212.86-1553.31%